Revelation Biosciences, Inc. (REVB) Stock
Healthcare · Biotechnology · Member of Other US Stocks
Revelation Biosciences, Inc. (REVB) closed at USD 0.72 on 2026-10-14, a change of -86.6 % over the past year, with a market capitalization of USD 3.04M.
Revelation Biosciences, Inc. recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 0.72 |
| 2026-10-13 | 0.73 |
| 2026-10-12 | 0.77 |
| 2026-10-09 | 0.76 |
| 2026-10-08 | 0.77 |
| 2026-10-07 | 0.83 |
| 2026-10-06 | 0.75 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
Revelation Biosciences, Inc. key figures
- Previous close
- USD 0.72 (2026-10-14)
- 1-year change
- -86.6 %
- Market cap
- USD 3.04M
- Enterprise value
- USD -7.71M
- P/E ratio (trailing)
- 0.17
- P/E ratio (forward)
- -0.26
- EPS (trailing)
- 4.60
- EPS (forward)
- -2.89
- PEG ratio
- n/a
- Price to book
- 0.30
- Revenue growth
- n/a
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.00
- Short ratio
- 0.06
- Employees
- 8
- Analyst consensus (third-party)
- none
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About Revelation Biosciences, Inc.
Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health. The company's lead product candidate is lead product candidate Gemini, a proprietary formulation platform of phosphorylated hexaacyl disaccharide (PHAD), an established Toll-like receptor 4 (TLR) agonist that works by modulating and rebalancing a dysregulated inflammatory response. It also engages in the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed its name to Revelation Biosciences, Inc. in January 2022. Revelation Biosciences, Inc. was incorporated in 2019 and is based in San Diego, California.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for Revelation Biosciences, Inc. and compare it with other stocks.
Analyze REVBAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Revelation Biosciences, Inc. shares.